Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / CL A
-
Number of holders
-
181
-
Total 13F shares, excl. options
-
22,169,198
-
Shares change
-
-1,043,214
-
Total reported value, excl. options
-
$2,159,297,534
-
Value change
-
-$198,458,474
-
Put/Call ratio
-
70%
-
Number of buys
-
92
-
Number of sells
-
-112
-
Price
-
$97.42
Significant Holders of REATA PHARMACEUTICALS INC - CL A (RETA) as of Q3 2020
254 filings reported holding RETA - REATA PHARMACEUTICALS INC - CL A as of Q3 2020.
REATA PHARMACEUTICALS INC - CL A (RETA) has 181 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22,169,198 shares
.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (3,989,752 shares), CPMG Inc (3,063,567 shares), VANGUARD GROUP INC (2,114,097 shares), FRANKLIN RESOURCES INC (1,393,654 shares), BlackRock Inc. (1,376,084 shares), PRICE T ROWE ASSOCIATES INC /MD/ (919,926 shares), Invesco Ltd. (562,631 shares), Duquesne Family Office LLC (543,901 shares), FMR LLC (492,416 shares), and PICTET ASSET MANAGEMENT LTD (468,378 shares).
This table shows the top 181 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.